IDEA #8X8GE5 Gene Therapy For Type I Diabetes Mellitus

Areas of Application The drug is used for the treatment of type I diabetes in endocrinology medical institutions Specifi cation The drug is based on polycations and recombinant DNA complexes containing the human preproinsulin gene. The preparation is prepared ex tempore, before administering. The pilot experiments with gene therapy for type I diabetes have been conducted. Positive results of treatment in long-term studies have been obtained Advantages There are no analogs in Ukraine. A single gene drug administration provides a long-term effect unlike the conventional treatment of type I diabetes mellitus with lifelong daily exogenous insulin injections to patients. The drug manufacturing costs are cheaper than those of similar foreign preparations based on the use of viruses for carrying therapeutic genes. This drug is safer since it is based on non-viral gene transfer system Stage of Development. Suggestion for Commercialization IRL3, TRL2 Seeking for partners for preclinical tests IPR Protection IPR2